Stock Screener App

Frei -

Installieren

Medical Devices

89.56

0.33% 0.3399

Medtronic Plc (MDT)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit Dividendenhistorie

Medtronic Plc Aktie (MDT) Neueste Nachrichten

Analyst Expectations For Medtronic's Future - Benzinga

Got Their Backs: How Medtronic Brings Spine Surgeries to Kids - Yahoo Finance

Medtronic gets CE mark for robot-driven vessel-sealing device - MedTech Dive

Baird Adjusts Medtronic Price Target to $94 From $92, Maintains Neutral Rating - MarketScreener

Morgan Stanley Adjusts Medtronic Price Target to $107 From $98, Maintains Overweight Rating - MarketScreener

Medtronic : first in the U.S. to offer 400 cm 0.018” peripheral guidewire for transradial access - MarketScreener

Medtronic, Renal Denervation, and the Power of Persistence - Medical Device and Diagnostic industry

Medtronic (MDT) Price Target Raised by Morgan Stanley | MDT Stoc - GuruFocus

Medtronic shaping future of surgery, secures CE Mark for LigaSure™ technology on Hugo™ robotic-assisted surgery system - Medtronic

Medtronic (MDT) Experiences Increased Bearish Options Activity | MDT Stock News - GuruFocus

Prostate Care Market Report 2025-2031 | Medtronic, Johnson & Johnson, Boston Scientific, and Abbott Laboratories Dominate through Product Innovations, Clinical Trials, M&As, and Strategic Partnerships - Yahoo Finance

Medtronic Stock Is Climbing Friday: What's Going On?Medtronic (NYSE:MDT) - Benzinga

Medtronic (MDT) Stock Insights and Investment Tools | MDT Stock News - GuruFocus

Medtronic (MDT) Gains from CMS Proposal on Renal Denervation Coverage | MDT Stock News - GuruFocus

Medtronic Says Centers for Medicare & Medicaid Services Proposes National Coverage for Blood Pressure Treatment Device - MarketScreener

Unusual Options Activity Noticed for Medtronic (MDT) | MDT Stock News - GuruFocus

Medtronic (MDT) Gains Following Medicare's Review of New Hypertension Technology | MDT Stock News - GuruFocus

William Blair reiterates Market Perform rating on Medtronic stock after CMS proposal - Investing.com

Medtronic, Recor praise new CMS coverage for renal denervation - MassDevice

The Best High Yield Medical Device Stock to Invest $1,000 in Right Now - The Motley Fool

Medtronic : issues statement on the U.S. Centers for Medicare & Medicaid Services proposed National Coverage Determination for Symplicity Spyral™ renal denervation (RDN) system - MarketScreener

Citi Analyst Boosts Medtronic (MDT) Price Target to $99 | MDT Stock News - GuruFocus

Needham Keeps Hold Rating on Medtronic (MDT) Amid Spin-Off News - MSN

Medtronic (MDT) Gains As Market Dips: What You Should Know - Yahoo Finance

Medtronic names CFO for diabetes spinoff - MedTech Dive

Medtronic announces appointment of MiniMed chief financial officer ahead of intended separation into standalone companyJul 8, 2025 - Medtronic

Why Is Merit Medical Stock Trading Higher On Tuesday?Merit Medical Systems (NASDAQ:MMSI) - Benzinga

First Patient Treated in Medtronic Multi-Organ SPYRAL GEMINI Pilot Study - Diagnostic and Interventional Cardiology

Medtronic Forges Ahead With Innovative Therapies - Morningstar

Those Who Invested in Medtronic (NYSE:MDT) a Year Ago Are up 19% - 富途牛牛

Medtronic’s SWOT analysis: stock poised for growth amid challenges - Investing.com

Wolfe Research Upgrades Medtronic (MDT) to Peer Perform - Insider Monkey

Why Medtronic is a Top 25 Dividend Giant (MDT) - Nasdaq

Medtronic: Cash Flow Strength Balanced By Execution Risks (NYSE:MDT) - Seeking Alpha

Medtronic announces strategic partnership with Philips to expand access to patient monitoring technology - Medtronic

Medtronic appoints new general counsel from another large medtech company - MassDevice

Tennis star Alexander Zverev partners with Medtronic to raise Diabetes awareness - Medical Device Network

Medtronic: Margin Inflection With Diabetes SpinKey Drivers (NYSE:MDT) - Seeking Alpha

Medtronic (MDT) Appoints Dr. Joon Sup Lee to Board of Directors - Yahoo

Technology M&A Practice Advised Rockley Photonics on Its Investment from Medtronic - Kroll

Medtronic's Trading Volume Drops 43.49% Ranking 152nd in Market - AInvest

What Makes Medtronic a Leader in Medical Devices - Yahoo Finance

Medtronic Stock Rated Outperform as Renal Denervation and Spin-Off Drive Growth Potential - Insider Monkey

Medtronic plc (NYSE:MDT) Is About To Go Ex-Dividend, And It Pays A 3.3% Yield - simplywall.st

Healthcare Tech Leader Medtronic Appoints Emory CEO Dr. Lee to Board: Brings $7.7B Healthcare System Expertise - Stock Titan

Medtronic plc SEC 10-K Report - TradingView

Medtronic Diabetes and tennis pro Alexander Zverev join forces to champion life without limits for people with diabetes - Medtronic

Medtronic training pact includes Hugo robot, cardiac ablation tech - MedTech Dive

Medtronic stock has significant opportunity in renal denervation, RBC says By Investing.com - Investing.com UK

FDA Clears Minimally Invasive Laser Ablation System from Medtronic for Epilepsy & Brain Tumors - Medical Device and Diagnostic industry

Medtronic partners with IRCAD on Hugo, Affera surgical training - MassDevice

Medtronic to invest $50 million over five years in Pune GCC - BusinessLine

Medtronic : IRCAD North America and Medtronic announce collaboration to advance surgical training and innovation - MarketScreener

Surgical Retractors Market Top Companies StudyMedtronic Plc, - openPR.com

Medtronic to invest $50 million over 5 years in Pune - PUNE PULSE

Medtronic plc Stock MDT Using Cash Flow Model NYSE Composite - Kalkine Media

A Look At The Fair Value Of Medtronic plc (NYSE:MDT) - simplywall.st

Medtronic to invest $50 million over 5 years in New Diabetes Global Capability Centre in Pune - Punekar News

Medtronic Invests $50M in Pune Diabetes Center - Rediff MoneyWiz

Leerink starts coverage on Boston Scientific and Medtronic with bullish ratings - Investing.com Nigeria

Leerink starts coverage on Boston Scientific and Medtronic with bullish ratings By Investing.com - Investing.com South Africa

Leerink Partners Initiates Coverage on Medtronic (MDT) with Outperform Rating | MDT Stock News - GuruFocus

Medtronic (MDT) Positioned for Growth Amid Strategic Shifts | MDT Stock News - GuruFocus

Leerink Partners Initiates Medtronic at Outperform With $110 Price Target - MarketScreener

Medtronic: Solid Recent Performance But Better Options Available (NYSE:MDT) - Seeking Alpha

Medtronic Doubles Down on Innovation as Cardiovascular Tech Takes Center Stage! - Smartkarma

Medtronic’s SWOT analysis: stock outlook amid diabetes spin-off and RDN growth - Investing.com

SYK

$388.98

0.44%

BSX

$102.96

0.49%

EW

$75.70

1.49%

GEHC

$75.81

2.12%

DXCM

$84.08

0.81%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters